Silencing mRNA expression in dendritic cells did not impair T‑cell priming, including for SARS‑CoV‑2 antigens, suggesting that cross‑presentation by other cell types is sufficient to initiate immunity ...
A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA ...
Add Yahoo as a preferred source to see more of our stories on Google. With a little help, your immune cells can be potent tumor killers. Steve Gschmeissner/Science Photo Library via Getty Images The ...
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...
New research from the University of Pittsburgh could help scientists develop the next generation of mRNA vaccines to be more effective and less expensive to produce. A study published this week in NPJ ...
A stabilized mRNA carrier turns tumor injection into broader immune activation by extending vaccine delivery to lymph nodes ...
With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...
A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...
WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...
Morning Overview on MSN
Early trial shows pancreatic cancer mRNA vaccine responses lasting 6 years
Six years after surgery for one of the deadliest cancers in medicine, a small group of patients who received a personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results